Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Pediatr Infect Dis J. 2011 Oct;30(10):844–849. doi: 10.1097/INF.0b013e31822e8b0b

FIGURE 2.

FIGURE 2

Meropenem measured cerebrospinal fluid (CSF)/predicted plasma concentration ratio: A) measured CSF/predicted plasma concentration ratio versus time of CSF collection (9 CSF sample data points; duplicate CSF samples collected 0.5 hours after dose overlap); B) measured CSF/predicted plasma concentration ratio versus white blood cell count (WBC) in the CSF (8 CSF sample data points with documented CSF WBC; duplicate CSF samples collected 0.5 hours after dose overlap).